While the ABCA3 expression level was significantly decreased in the CML-CP (median: 0.025; p <0.0001), AML-CR (median: 0.078; p=0.0011) and CML-CR (median: 0.037; p <0.0001) in comparison with the HI group. This evidence concerns the gene ABCA3 and acute myeloid leukemia.